NDAINTRAMUSCULAR, SUBCUTANEOUSSOLUTIONPriority Review
Approved
Aug 2024
Lifecycle
Growth
Competitive Pressure
0/100
Clinical Trials
1
Clinical Trials (1)
Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence
Started Oct 2019
533 enrolled
Alcohol Dependence
Loss of Exclusivity
LOE Date
Nov 5, 2039
166 months away
Patent Expiry
Nov 5, 2039
Exclusivity Expiry
Aug 7, 2027
Company
Purdue Pharma
CT - Stamford